logo
Select company
Select metric
$ 25.64MNet Cash Flow - Financing
VS
Market
26
Sector
28
Industry
36
History
70
$ 5.62Close
$ 3.81 - $ 9.02 52-Week Range
Ticker Information

Ticker

DTIL

Company Name

PRECISION BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PRECISION BIOSCIENCES INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DTIL - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 25.64M
3/31/2025$ 21.04M
12/31/2024$ 50.45M
9/30/2024$ 47.36M
6/30/2024$ 43.59M
3/31/2024$ 44.74M
12/31/2023$ 5.39M
9/30/2023$ 2.56M
6/30/2023$ 2.41M
3/31/2023$ 93.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRECISION BIOSCIENCES INC's latest trailing twelve months (TTM) CF - Financing stands at $ 1.84M.
  • Over the past 5 years, PRECISION BIOSCIENCES INC's average CF - Financing has been $ 45.56M.
  • The median CF - Financing for PRECISION BIOSCIENCES INC during this period was $ 44.17M
  • PRECISION BIOSCIENCES INC reached its highest CF - Financing over the past 5 years at $ 115.46M.
  • The lowest CF - Financing recorded by PRECISION BIOSCIENCES INC in the same timeframe $ 1.33M

PRECISION BIOSCIENCES INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
ADVM : ADVERUM BIOTECHNOLOGIES INC $ 359KRANI : RANI THERAPEUTICS HOLDINGS INC $ 9.78MPLUR : PLURI INC $ 9.53MIGC : IGC PHARMA INC $ 2.79MCLSD : CLEARSIDE BIOMEDICAL INC $ 2.02MRNXT : RENOVORX INC $ 10.89MLSTA : LISATA THERAPEUTICS INC $ -55KSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.09MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 8.43MSER : SERINA THERAPEUTICS INC $ 15.6M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

DTIL - Net Cash Flow - Financing, Last 5 years

$ 1.33M

Minimum

Dec 31, 2020

$ 115.46M

Maximum

Jun 30, 2022

$ 45.56M

Average

$ 44.17M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M